Education
About Us
Working with TipRanks
Follow Us
Shield Therapeutics (GB:STX)
:STX
See the Price Targets and Ratings of:
STX Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
2.5p
Hold
-0.79%
Downside
Reiterated
06/11/25
The overall stock score is driven primarily by financial challenges, including negative profitability and cash flow issues, which are significant risks. Technical analysis and valuation also suggest caution. Positive corporate developments offer potential for future improvement but don't alleviate near-term financial concerns.
Stifel Nicolaus
3.5p→3.8p
Hold
50.79%
Upside
Reiterated
02/19/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
2.5p
Hold
-0.79%
Downside
Reiterated
06/11/25
The overall stock score is driven primarily by financial challenges, including negative profitability and cash flow issues, which are significant risks. Technical analysis and valuation also suggest caution. Positive corporate developments offer potential for future improvement but don't alleviate near-term financial concerns.
Stifel Nicolaus
3.5p→3.8p
Hold
50.79%
Upside
Reiterated
02/19/25
STX Analyst Recommendation Trends
Rating
Nov 23
Apr 24
Jul 24
Sep 24
Feb 25
Strong Buy
0
0
0
0
0
Buy
3
2
1
0
0
Hold
0
1
2
3
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
4
Each month's total comprises the sum of three months' worth of ratings.
STX Stock Forecast FAQ
What is GB:STX’s average 12-month price target, according to analysts?
Based on analyst ratings, Shield Therapeutics’s 12-month average price target is 3.80.
What is GB:STX’s upside potential, based on the analysts’ average price target?
Shield Therapeutics has 50.79% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Shield Therapeutics a Buy, Sell or Hold?
Shield Therapeutics has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Shield Therapeutics’s share price target?
The average share price target for Shield Therapeutics is 3.80. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 3.80p ,and the lowest forecast is 3.80p. The average share price target represents 50.79% Increase from the current price of 2.52p.
The highest analyst share price target is 3.80p ,and the lowest forecast is 3.80p. The average share price target represents 50.79% Increase from the current price of 2.52p.
What do analysts say about Shield Therapeutics?
Shield Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Shield Therapeutics?
To buy shares of GB:STX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.